Mark W. Schwartz

Board Member at NeoLight

Mark is the Vice President, Business Development for NeoLight. Among other executive positions, he has served as CEO of Galena Biopharma (NASDAQ), Apthera, Bayhill Therapeutics and Caylx Therapeutics. Mark’s extensive experience across operational and strategic management in early stage companies led him to his new role at NeoLight. He is an adjunct faculty member at San Jose State University and currently serves as a Director of Targazyme, Inc.

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


NeoLight

NeoLight is a modern medical device company that engineers, designs and manufactures technologies that treat infants with life threatening medical conditions.


Industries

Employees

11-50

Links